Table 1.

Distribution of Risk Factors for FN, and Anemia or RBC Transfusions by Treatment Group

Risk Category, n (%)	Trilaciclib (n=123)	Placebo (n=119)
FN
No risk factors	32 (26.0)	35 (29.4)
1/2 risk factors	85 (69.1)	77 (64.7)
3/4 risk factors	6 (4.9)	7 (5.9)
5/6 risk factors	0	0
Chi-square P-value*	0.7632
Anemia or RBC transfusions
No risk factors	48 (39.0)	47 (39.5)
1/2 risk factors	68 (55.3)	62 (52.1)
3/4 risk factors	7 (5.7)	10 (8.4)
Chi-square P-value*	0.6870

Note: *Calculated to test the treatment-by-risk-category association.

Abbreviations: FN, febrile neutropenia; RBC, red blood cell.